Bad Breakups, Lisata (Nasdaq: LSTA) sues Kuva Labs after merger collapse Lisata Therapeutics, Inc. (Nasdaq: LSTA) has filed suit in the Delaware Court of Chancery against Kuva Labs Inc. and its subsidiary Kuva Acquisition Corp. following the termination of a merger...
A deal to reduce debt, Hydrofarm sells Aurora Peat for $16M, launches Project Agility Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) has completed the sale of Aurora Peat Products ULC to Raven Holdings LLC, a private company, for $16 million. The deal includes a $5...
Putting your money where your mouth is, Curium to acquire Lantheus in deal valued at up to $8 billion Curium, a radiopharmaceutical company controlled by private equity firm CapVest Partners, has entered into a definitive agreement to acquire all outstanding shares of...
Solid bet, ATIF Holdings to acquire GoldCoin Labs in $20M all-share deal ATIF Holdings Limited (NASDAQ: AUC), a California-based financial consulting company, announced it has entered into a definitive agreement to acquire GoldCoin Labs Limited, a British Virgin...
This has been a rough week for the Biotech Market, Novo Nordisk’s fails to reduce heart risk in ZEUS trial Novo Nordisk (NYSE: NVO) announced that its experimental drug ziltivekimab did not reduce the risk of major adverse cardiovascular events (MACE) in a phase 3...
